• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖皮质激素受体、SGK1 和 NDRG1 在激素初治前列腺癌中的表达及临床病理意义。

Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and NDRG1 in hormone-naïve prostate carcinoma.

机构信息

Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyagino-ku, Sendai, Miyagi, 983-8536, Japan.

Department of Pathology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

出版信息

Med Mol Morphol. 2022 Dec;55(4):283-291. doi: 10.1007/s00795-022-00332-x. Epub 2022 Jul 21.

DOI:10.1007/s00795-022-00332-x
PMID:35861941
Abstract

Glucocorticoid receptor (GR) has been implicated in prostate carcinoma growth and progression. Glucocorticoid receptor beta (GRβ) acts as an inhibitor of GR; however, its function is not well understood. Serum- and glucocorticoid-regulated kinase 1 (SGK1) is a GR-responsive gene that phosphorylates N-myc downstream-regulated gene 1 (NDRG1) and is involved in cancer growth and invasion. However, the expression of GR, GRβ, SGK1, and NDRG1 in prostate cancer and their relationship with clinicopathological and functional significance remain unknown. The association between the status of GR, GRβ, SGK1, and NDRG1 immunoreactivity and clinicopathological variables was analyzed in patients with prostate carcinoma to explore their clinical significance. In prostate carcinoma cases, the relative abundance of GR and NDRG1 immunoreactivity was inversely and significantly associated with the primary tumor stage (pT), while GR immunoreactivity was inversely and significantly associated with the Ki-67 score. The relative expression status of NDRG1 was significantly associated with that of GR. However, no significant correlation was observed between any of the clinicopathological parameters and GRβ and SGK1 expression. Our findings indicate that GR and NDRG1 expression status is correlated with clinicopathological features in patients with prostate cancer.

摘要

糖皮质激素受体(GR)已被牵连到前列腺癌的生长和进展中。糖皮质激素受体β(GRβ)作为 GR 的抑制剂;然而,其功能尚不清楚。血清和糖皮质激素调节激酶 1(SGK1)是一种 GR 反应基因,可磷酸化 N-myc 下游调节基因 1(NDRG1),并参与癌症的生长和侵袭。然而,前列腺癌中 GR、GRβ、SGK1 和 NDRG1 的表达及其与临床病理和功能意义的关系尚不清楚。分析了前列腺癌患者中 GR、GRβ、SGK1 和 NDRG1 免疫反应的状态与临床病理变量之间的关系,以探讨其临床意义。在前列腺癌病例中,GR 和 NDRG1 免疫反应的相对丰度与原发性肿瘤分期(pT)呈负相关且显著相关,而 GR 免疫反应与 Ki-67 评分呈负相关且显著相关。NDRG1 的相对表达状态与 GR 显著相关。然而,任何临床病理参数与 GRβ 和 SGK1 表达之间均未观察到显著相关性。我们的研究结果表明,GR 和 NDRG1 的表达状态与前列腺癌患者的临床病理特征相关。

相似文献

1
Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and NDRG1 in hormone-naïve prostate carcinoma.糖皮质激素受体、SGK1 和 NDRG1 在激素初治前列腺癌中的表达及临床病理意义。
Med Mol Morphol. 2022 Dec;55(4):283-291. doi: 10.1007/s00795-022-00332-x. Epub 2022 Jul 21.
2
GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.食管鳞状细胞癌中 GR、Sgk1 和 NDRG1:与新辅助化疗治疗效果的相关性。
BMC Cancer. 2020 Feb 27;20(1):161. doi: 10.1186/s12885-020-6652-7.
3
The GR-SGK1-NDRG1 Pathway as a Predictor of Recurrence and Prognosis in Lung Adenocarcinoma After Radical Surgery.GR-SGK1-NDRG1 通路作为肺腺癌根治术后复发和预后的预测因子。
Anticancer Res. 2023 Jul;43(7):2965-2974. doi: 10.21873/anticanres.16467.
4
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.糖皮质激素受体活性有助于前列腺癌对雄激素靶向治疗的抵抗。
Horm Cancer. 2014 Apr;5(2):72-89. doi: 10.1007/s12672-014-0173-2. Epub 2014 Mar 11.
5
Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.血清/糖皮质激素调节激酶 1 在原发性人前列腺癌中的表达。
Prostate. 2012 Feb 1;72(2):157-64. doi: 10.1002/pros.21416. Epub 2011 May 11.
6
Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.辐射诱导的糖皮质激素受体通过激活 SGK1-Wnt/β-catenin 信号通路促进 CD44+前列腺癌干细胞生长。
J Mol Med (Berl). 2019 Aug;97(8):1169-1182. doi: 10.1007/s00109-019-01807-8. Epub 2019 Jun 11.
7
Up-regulation of the kinase gene by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells.孕激素通过上调激酶基因激活 PR 阳性和阴性乳腺癌细胞中的 AP-1-NDRG1 轴。
J Biol Chem. 2018 Dec 14;293(50):19263-19276. doi: 10.1074/jbc.RA118.002894. Epub 2018 Oct 18.
8
Oncogenic MNK signalling regulates the metastasis suppressor NDRG1.致癌性MNK信号传导调控转移抑制因子NDRG1。
Oncotarget. 2017 Jul 11;8(28):46121-46135. doi: 10.18632/oncotarget.17555.
9
Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells.鉴定受 SGK1 丝氨酸/苏氨酸磷酸化作用影响的位点,这些位点会影响 N-myc 下游调节基因 1(NDRG1)/Cap43 依赖性抑制人胰腺癌细胞中血管生成 CXC 趋化因子表达。
Biochem Biophys Res Commun. 2010 May 28;396(2):376-81. doi: 10.1016/j.bbrc.2010.04.100. Epub 2010 Apr 21.
10
SGK1 activity in Na+ absorbing airway epithelial cells monitored by assaying NDRG1-Thr346/356/366 phosphorylation.通过检测NDRG1-Thr346/356/366磷酸化来监测钠吸收气道上皮细胞中的SGK1活性。
Pflugers Arch. 2009 Apr;457(6):1287-301. doi: 10.1007/s00424-008-0587-1. Epub 2008 Sep 12.

引用本文的文献

1
Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer-directs the road towards therapy resistance, metastatic progression and recurrence.糖皮质激素受体:乳腺癌细胞可塑性的协调者——指向治疗耐药、转移进展和复发的方向。
Cancer Metastasis Rev. 2024 Mar;43(1):481-499. doi: 10.1007/s10555-023-10163-6. Epub 2024 Jan 3.

本文引用的文献

1
The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer.抑瘤基因 NDRG1 直接调控前列腺癌中的雄激素受体信号转导。
J Biol Chem. 2021 Dec;297(6):101414. doi: 10.1016/j.jbc.2021.101414. Epub 2021 Nov 14.
2
Glucocorticoid receptor and serum- and glucocorticoid-induced kinase-1 in esophageal adenocarcinoma and adjacent Barrett's esophagus.食管腺癌和相邻 Barrett 食管中的糖皮质激素受体和血清及糖皮质激素诱导的激酶 1。
Pathol Int. 2020 Jun;70(6):355-363. doi: 10.1111/pin.12922. Epub 2020 Mar 15.
3
GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy.
食管鳞状细胞癌中 GR、Sgk1 和 NDRG1:与新辅助化疗治疗效果的相关性。
BMC Cancer. 2020 Feb 27;20(1):161. doi: 10.1186/s12885-020-6652-7.
4
Glucocorticoids rapidly activate cAMP production via G to initiate non-genomic signaling that contributes to one-third of their canonical genomic effects.糖皮质激素通过 G 蛋白快速激活 cAMP 产生,从而启动非基因组信号转导,这有助于其三分之一的经典基因组效应。
FASEB J. 2020 Feb;34(2):2882-2895. doi: 10.1096/fj.201902521R. Epub 2019 Dec 27.
5
Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer.糖皮质激素受体上调会增加前列腺癌的放射抗性并引发雄激素非依赖性。
Prostate. 2019 Sep;79(12):1386-1398. doi: 10.1002/pros.23861. Epub 2019 Jul 23.
6
Non-genomic Effects of Glucocorticoids: An Updated View.糖皮质激素的非基因组效应:最新观点。
Trends Pharmacol Sci. 2019 Jan;40(1):38-49. doi: 10.1016/j.tips.2018.11.002. Epub 2018 Nov 26.
7
Therapeutic inhibition of SGK1 suppresses colorectal cancer.SGK1 的治疗性抑制可抑制结直肠癌。
Exp Mol Med. 2017 Nov 24;49(11):e399. doi: 10.1038/emm.2017.184.
8
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy.糖皮质激素受体是前列腺癌细胞存活的关键因素,也是改善抗雄激素治疗的靶点。
Clin Cancer Res. 2018 Feb 15;24(4):927-938. doi: 10.1158/1078-0432.CCR-17-0989. Epub 2017 Nov 20.
9
Expression of AR, 5αR1 and 5αR2 in bladder urothelial carcinoma and relationship to clinicopathological factors.雄激素受体、5α还原酶1和5α还原酶2在膀胱尿路上皮癌中的表达及其与临床病理因素的关系。
Life Sci. 2017 Dec 1;190:15-20. doi: 10.1016/j.lfs.2017.09.029. Epub 2017 Sep 23.
10
Development of a new analog of SGK1 inhibitor and its evaluation as a therapeutic molecule of colorectal cancer.一种新型SGK1抑制剂类似物的研发及其作为结直肠癌治疗分子的评估。
J Cancer. 2017 Jul 20;8(12):2256-2262. doi: 10.7150/jca.19566. eCollection 2017.